Cynthia Korin Bullen (C Korin Bullen)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Coronavirus Disease

Dendritic Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

bioRxiv : the preprint server for biology

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Alvaro A Ordonez, Cynthia Korin Bullen, Andres F Villabona-Rueda, Elizabeth A Thompson, Mitchell L Turner, Vanessa F Merino, Yu Yan, John Kim, Stephanie L Davis, Oliver Komm, Jonathan D Powell, Franco R D'Alessio, Robert H Yolken, Sanjay K Jain, Lorraine Jones-Brando
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Communications biology 5 (1) (2022)
Alvaro A Ordonez, Cynthia Korin Bullen, Andres F Villabona-Rueda, Elizabeth A Thompson, Mitchell L Turner, Stephanie L Davis, Oliver Komm, Jonathan D Powell, Franco R D'Alessio, Robert H Yolken, Sanjay K Jain, Lorraine Jones-Brando
Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses. bioRxiv : the preprint server for biology (2021)
Andrew Timmons, Emily J Fray, Mithra R Kumar, Fengting Wu, Weiwei Dai, Cynthia Korin Bullen, Peggy Kim, Carrie Hetzel, Chao Yang, Subul Beg, Jun Lai, Joel L Pomerantz, Steven A Yukl, Janet D Siliciano, Robert F Siliciano
HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo. Proceedings of the National Academy of Sciences of the United States of America 117 (27) (2020)